 |
|
yttrium Y 90 ibritumomab tiuxetan
A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 90Y ibritumomab tiuxetan
Ibritumomab (In2B8/Y2B8 Radiolabeling Kit)
Ibritumomab Tiuxetan
IDEC-Y2B8 Monoclonal Antibody
Y90 Zevalin
Y90-labeled ibritumomab tiuxetan
Yttrium-90 Ibritumomab Tiuxetan | | | | US brand name: | | Zevalin | | | | Code name: | | IDEC Y2B8 | | |
|
|
